Artificial Intelligence, Kidney Diseases, Ophthalmology
Conditions
Keywords
Kidney Diseases, Artificial Intelligence, Eye information
Brief summary
This is an retrospective and prospective multicenter study to develop and validate an artificial intelligent (AI) aided diagnosis, therapeutic effect assessment model including chronic kidney disease (CKD) and dialysis patients starting from April 2009, which is based on ophthalmic examinations (e.g. retinal fundus photography, slit-lamp images, OCTA, etc.) and CKD diagnostic and therapeutic data (routine clinical evaluations and laboratory data), to provide a reliable basis and guideline for clinical diagnosis and treatment.
Interventions
The development datasets were used to train the deep learning model, which was validated and tested by the other 4 datasets.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients previously received kidney biopsy, ophthalmic examinations and routine examinations of the department of nephrology during in-hospital period with BCVA\>0.5.
Exclusion criteria
* Patients without retinal fundus images or kidney diseases. * The quality of the retinal fundus images can not meet the requirement for furthur analysis. * Severe loss of results of routine examinations of the department of nephrology.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Area under the receiver operating characteristic curve of the deep learning system | baseline | The investigators will calculate the area under the receiver operating characteristic curve of deep learning system and compare this index between deep learning system and human doctors |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sensitivity and specificity of the deep learning system | baseline | The investigators will calculate the sensitivity and specifity of deep learning system and compare this index between deep learning system and human doctors |
Countries
China